Evidence map›Paper›PMID 38626070›Full record

ArticlePloS one2024

High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.

Nasimu Kyakuwa, Geofrey Kimbugwe, Flavia Nakanjako, Hamza Kalute, Simon Mpooya, Christine Atuhairwe, Laurent Perez, Bernard Kikaire

Abstract readAdaptive Clinical Trial
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasimu KyakuwaUganda Virus Research Institute, Entebbe, Uganda.ORCID 0000-0002-9671-1282
Geofrey KimbugweMRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda.
Flavia NakanjakoUganda Virus Research Institute, Entebbe, Uganda.
Hamza KaluteUganda Virus Research Institute, Entebbe, Uganda.
Simon MpooyaUganda Virus Research Institute, Entebbe, Uganda.
Christine AtuhairweUganda Martyrs University, Entebbe, Uganda.
Laurent PerezUniversity of Lausanne, Lausanne, Switzerland.
Bernard KikaireMakerere University College of Health Sciences, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of the study was to describe the facilitators, barriers to and level of uptake of COVID-19 vaccines among healthcare workers in primary healthcare facilities in an urban setting in Uganda. MATERIALS AND

methodsWe conducted a cross-sectional study among HCWs in private and public health facilities in Entebbe municipality between July 2021 and August 2021. Data was collected using a structured questionnaire that was shared, via an online link, to consented participants. Uptake of the vaccines among healthcare workers was analysed as proportions, and logistic regression was used to analyse barriers and facilitators to uptake of COVID-19 vaccines.

resultsThe study enrolled 360 participants, with 61.7% (n = 222) females. A total of 236 (65.6%) healthcare workers had received at least one dose of COVID-19 vaccine, with higher uptake among females 64% (n = 151). Age above 40 years (OR 2.16), working in a government healthcare facility (OR 3.12), participating in COVID-19 vaccine related activities (OR 4.62), and having tested for SARS-COV-2 (OR 3.05) increased the odds of having been vaccinated. Working in small roadside clinics reduced the odds of being vaccinated by almost 70%, while HCWs in government health services were 3.1 times more likely to have been vaccinated. History of having cared for a COVID-19 patient and having a positive SARS-COV-2 test result did not influence the uptake of the vaccines in the study population.

conclusionVaccine uptake among HCWs was close to the World Health Organisation (WHO) recommended uptake of 70% by mid-2022.

Indexed as

COVID-19COVID-19 VaccinesAdultCross-Sectional StudiesFemaleHealth PersonnelHumansSARS-CoV-2UgandaVaccinationCOVID-19 Vaccines

Identifiers

PMID38626070
PMCPMC11020364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.